TIAA CREF Investment Management LLC decreased its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 6.5% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 78,660 shares of the semiconductor company’s stock after selling 5,503 shares during the period. TIAA CREF Investment Management LLC’s holdings in Axcelis Technologies were worth $1,479,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Metropolitan Life Insurance Co. NY boosted its stake in Axcelis Technologies by 11.1% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 20,593 shares of the semiconductor company’s stock valued at $300,000 after buying an additional 2,060 shares in the last quarter. American International Group Inc. raised its position in shares of Axcelis Technologies by 7.1% in the first quarter. American International Group Inc. now owns 17,943 shares of the semiconductor company’s stock valued at $337,000 after buying an additional 1,184 shares during the last quarter. KBC Group NV raised its position in shares of Axcelis Technologies by 18.3% in the first quarter. KBC Group NV now owns 32,443 shares of the semiconductor company’s stock valued at $610,000 after buying an additional 5,020 shares during the last quarter. Teachers Advisors LLC raised its position in shares of Axcelis Technologies by 4.0% in the fourth quarter. Teachers Advisors LLC now owns 46,666 shares of the semiconductor company’s stock valued at $679,000 after buying an additional 1,786 shares during the last quarter. Finally, Russell Investments Group Ltd. purchased a new position in shares of Axcelis Technologies during the first quarter valued at about $875,000. 77.13% of the stock is owned by institutional investors and hedge funds.

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) traded up 4.37% on Friday, reaching $20.30. The company’s stock had a trading volume of 448,519 shares. Axcelis Technologies, Inc. has a 12-month low of $11.05 and a 12-month high of $26.53. The company has a market cap of $633.83 million, a P/E ratio of 21.78 and a beta of 1.11. The company’s 50 day moving average price is $21.98 and its 200 day moving average price is $19.50.

Axcelis Technologies (NASDAQ:ACLS) last posted its earnings results on Thursday, August 3rd. The semiconductor company reported $0.33 earnings per share for the quarter, missing analysts’ consensus estimates of $0.34 by $0.01. Axcelis Technologies had a return on equity of 12.52% and a net margin of 9.10%. The firm had revenue of $102.80 million for the quarter, compared to analysts’ expectations of $100.07 million. During the same quarter last year, the company posted $0.10 EPS. The firm’s revenue was up 59.4% on a year-over-year basis. Analysts forecast that Axcelis Technologies, Inc. will post $1.25 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/12/axcelis-technologies-inc-nasdaqacls-stake-reduced-by-tiaa-cref-investment-management-llc.html.

Several brokerages have issued reports on ACLS. B. Riley reiterated a “buy” rating and issued a $30.00 price target on shares of Axcelis Technologies in a report on Friday, August 4th. Benchmark Co. reiterated a “buy” rating and issued a $24.00 price target (up previously from $21.00) on shares of Axcelis Technologies in a report on Friday, May 5th. Zacks Investment Research lowered Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 5th. Needham & Company LLC reiterated a “buy” rating and issued a $23.00 price target (up previously from $20.00) on shares of Axcelis Technologies in a report on Friday, May 5th. Finally, Wedbush increased their price target on Axcelis Technologies from $23.00 to $27.00 in a report on Friday, June 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $24.67.

In other Axcelis Technologies news, CFO Kevin J. Brewer sold 93,750 shares of the company’s stock in a transaction that occurred on Friday, May 26th. The stock was sold at an average price of $21.94, for a total transaction of $2,056,875.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Joseph P. Keithley sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $24.58, for a total value of $491,600.00. The disclosure for this sale can be found here. Insiders have sold a total of 284,267 shares of company stock worth $6,440,086 in the last quarter. Company insiders own 5.66% of the company’s stock.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training.

Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS).

Institutional Ownership by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.